Aurinia PharmaceuticalsvsMerck & Company

AUPH and MRK stock compared: price, dividend, valuation and results, from SEC filings.

AUPH

Aurinia Pharmaceuticals Inc

$15.31

Value $2.0B

-1.16%
AUPH's page

MRK

Merck & Company, Inc.

$144.30

Value $357B

-0.25%
MRK's page

Aurinia Pharmaceuticals (AUPH) has a market value of $2.0B and Merck & Company (MRK) $357B. Over the last year, with dividends, AUPH moved -0.3% and MRK +59.6%. Dividend yield: AUPH none, MRK 2.36%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AUPH$2.0B

    MRK$357B

    MRK is 175 times AUPH

  • Revenue, 12 months

    AUPH$322M

    MRK$67.4B

    MRK is 209 times AUPH

  • Net income, 12 months

    AUPH$314M

    MRK$2.5B

    MRK is 7.8 times AUPH

  • Operating margin

    AUPH48.6%

    MRK–

  • ROIC

    AUPH22.2%

    MRK3.9%

    18.3 points apart

  • P/E

    AUPH–

    MRK145.4

  • Dividend yield

    AUPH0.0%

    MRK2.4%

    2.4 points apart

  • 5-year return

    AUPH-44.5%

    MRK+99.5%

    144.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AUPH-44.5%

MRK+99.5%

10020020222023202420252026
Returns by period
PeriodAUPHWith dividendsMRKWith dividends
1 year since November 14, 2025-0.3%Price -0.3%+59.6%Price +55.0%
3 years since November 17, 2023+77.9%+21.2% a yearPrice +77.9%+55.2%+15.8% a yearPrice +41.6%
5 years since November 16, 2021-44.5%-11.1% a yearPrice -44.5%+99.5%+14.8% a yearPrice +71.3%
10 years since November 17, 2016+346.1%+16.1% a yearPrice +346.1%+226.7%+12.6% a yearPrice +140.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AUPHAurinia PharmaceuticalsMRKMerck & Company

Valuation

AUPHMRK
Valuation
Price$15.31$144.30
Market value$2.0B$357B
Enterprise value (EV)$1.6B$401B
P/E–145.4
P/E, 5-year median–14.8
P/B3.18.0
EV/EBIT10.384.2
Free cash flow yield8.7%4.1%

Results and growth

AUPHMRK
Results and growth
Revenue, 12 months$322M$67.4B
Net income, 12 months$314M$2.5B
Free cash flow, 12 months$177M$14.7B
Earnings per share, 12 months$2.29$0.98
Revenue growth, year on year20.4%1.3%
Revenue growth a year, past+41.4%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

AUPHMRK
Margins and returns on capital
Gross margin90.6%71.8%
Operating margin48.6%–
Net margin97.7%3.6%
ROIC22.2%3.9%
ROE56.4%5.2%

Balance sheet

AUPHMRK
Balance sheet
Cash$487M$9.7B
Total debt$59M$53.8B
Net debt / EBITDA-2.55.7
Interest cover40.4×2.4×

Dividends and buybacks

AUPHMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield4.8%1.4%
Shareholder yield4.8%3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AUPH or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Aurinia Pharmaceuticals or Merck & Company?

By market value, Merck & Company ($357B) is about 175.2 times Aurinia Pharmaceuticals ($2.0B), at today's prices.

How did AUPH and MRK stock do over the last 10 years?

Since November 17, 2016, AUPH's price moved +346.1% and MRK's +140.7%. With dividends: AUPH +346.1% (+16.1% a year), MRK +226.7% (+12.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, AUPH or MRK?

The dividend yield at today's price is none for Aurinia Pharmaceuticals and 2.36% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, Aurinia Pharmaceuticals or Merck & Company?

Over the last twelve months, the net margin was 97.7% for Aurinia Pharmaceuticals and 3.6% for Merck & Company, and the operating margin 48.6% and –. Revenue was $322M and $67.4B.

Which is the better investment, Aurinia Pharmaceuticals or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.